scholarly article | Q13442814 |
P356 | DOI | 10.1097/00000542-199612000-00017 |
P698 | PubMed publication ID | 8968183 |
P2093 | author name string | Inturrisi CE | |
Shimoyama M | |||
Elliott KJ | |||
Shimoyama N | |||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | morphine | Q81225 |
P304 | page(s) | 1357-1366 | |
P577 | publication date | 1996-12-01 | |
P1433 | published in | Anesthesiology | Q2012635 |
P1476 | title | Ketamine attenuates and reverses morphine tolerance in rodents. | |
P478 | volume | 85 |
Q42543643 | Acute tolerance associated with a single opiate administration: involvement of N-methyl-D-aspartate-dependent pain facilitatory systems |
Q43540620 | Attenuation of hyperalgesia by LY235959, a competitive N-methyl-D-aspartate receptor antagonist |
Q42126244 | Blockade and reversal of spinal morphine tolerance by peptide and non-peptide calcitonin gene-related peptide receptor antagonists |
Q41700902 | Combined opioid-NMDA antagonist therapies. What advantages do they offer for the control of pain syndromes? |
Q42757575 | Comparative effects of cyclo-oxygenase and nitric oxide synthase inhibition on the development and reversal of spinal opioid tolerance |
Q37206140 | Differential Postoperative Effects of Volatile Anesthesia and Intraoperative Remifentanil Infusion in 7511 Thyroidectomy Patients: A Propensity Score Matching Analysis. |
Q90087607 | Effect of morphine and a low dose of ketamine on the T cells of patients with refractory cancer pain in vitro |
Q78006955 | Effects of NMDA receptor antagonists on morphine tolerance: a c-Fos study in the lumbar spinal cord of the rat |
Q41686418 | Endogenous opiates: 1996. |
Q43604538 | Inhibition of morphine tolerance and dependence by MS-153, a glutamate transporter activator |
Q46859036 | Intrathecal antinociceptive interaction between the NMDA antagonist ketamine and the opioids, morphine and biphalin |
Q44344030 | Ketamine Infusion as a Counter Measure for Opioid Tolerance in Mechanically Ventilated Children: A Pilot Study |
Q40920574 | Ketamine coadministration attenuates morphine tolerance and leads to increased brain concentrations of both drugs in the rat. |
Q45939966 | Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings). |
Q41910230 | Ketamine, as adjuvant analgesics for patients with refractory cancer pain, does affect IL-2/IFN-γ expression of T cells in vitro?: A prospective, randomized, double-blind study |
Q39341610 | Managing chronic whiplash associated pain with a combination of low-dose opioid (remifentanil) and NMDA-antagonist (ketamine). |
Q90732131 | Mitogen-Activated Protein Kinase Signaling Mediates Morphine Induced-Delayed Hyperalgesia |
Q35044033 | N-methyl-D-aspartate- enhanced analgesia |
Q51379157 | Neurophysiology of Cancer Pain: From the Laboratory to the Clinic. |
Q51448923 | Peripheral blockade of topical morphine tolerance by ketamine. |
Q79362825 | Primary afferent NMDA receptors increase dorsal horn excitation and mediate opiate tolerance in neonatal rats |
Q44341481 | Prior ibuprofen exposure does not augment opioid drug potency or modify opioid requirements for pain inhibition in total hip surgery |
Q46545594 | Safety of mixture of morphine with ketamine for postoperative patient-controlled analgesia: an audit with 1026 patients |
Q43263235 | Spinal administration of lipoxygenase inhibitors suppresses behavioural and neurochemical manifestations of naloxone-precipitated opioid withdrawal |
Q39458348 | Spinal gabapentin is antinociceptive in the rat formalin test |
Q34395115 | Synthesis and determination of chronic and acute thermal and chemical pain activities of a new derivative of phencyclidine in rats |
Q51375067 | The effects of midazolam and morphine on analgesic and sedative activity of ketamine in rats. |
Q44035253 | The involvement of nitric oxide in the analgesic effects of ketamine |
Q35164063 | The neurobiology of opiate tolerance, dependence and sensitization: mechanisms of NMDA receptor-dependent synaptic plasticity |
Q34321128 | The nonmedical use of ketamine, part two: A review of problem use and dependence |
Q24677387 | The role of spinal neuropeptides and prostaglandins in opioid physical dependence |
Q30428413 | Tolerance and withdrawal from prolonged opioid use in critically ill children |
Q39382936 | Treatment of extreme tumour pain with morphine and s-ketamine A case report of an 11-year old girl |
Q73213332 | [Mechanisms of opioid tolerance and opioid dependence] |
Search more.